EcoDrugPlus

Cathepsin S-Like

Ensembl ID : ENSSLUG00000007493
Gene Symbol: LOC116049093
3 Cross references
233 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSSLUG00000010234
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSSLUG00000010954
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSSLUG00000017525
Gene Symbol: CHEK2
1 Cross references
205 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 4a

Ensembl ID : ENSSLUG00000002135
Gene Symbol: CXCR4A
1 Cross references
201 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSSLUG00000022732
Gene Symbol: CCKAR
3 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSSLUG00000020856
Gene Symbol: CCKBR
3 Cross references
191 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSSLUG00000025853
Gene Symbol: LOC116044583
3 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSSLUG00000007056
Gene Symbol: LOC116041944
3 Cross references
258 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSSLUG00000025699
Gene Symbol: CETP
3 Cross references
137 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSSLUG00000014763
Gene Symbol: CHRM2
3 Cross references
195 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSSLUG00000025717
Gene Symbol: CHRM2
3 Cross references
185 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).